Sarcopenia, the age-related decline in skeletal muscle mass and function, is one of the main contributors to morbidity and physical disability (1). In women, menopause may contribute to sarcopenia, which not only affects very old wom-en but can also have impact on middle-aged adults (2). Changes in the gonadal hormones dur-ing the menopause transition appear to be a strong determinant of skeletal muscle mass in women. . . .